Loaiza-Moss Jocshan, Braun Ursula, Leitges Michael
Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, 300 Prince Philip Drive, St. Johns, NL A1B 3V6, Canada.
Int J Mol Sci. 2025 Jan 12;26(2):596. doi: 10.3390/ijms26020596.
Cell immortalization corresponds to a biologically relevant clinical feature that allows cells to acquire a high proliferative potential during carcinogenesis. In multiple cancer types, Protein Kinase D3 (PKD3) has often been reported as a dysregulated oncogenic kinase that promotes cell proliferation. Using mouse embryonic fibroblasts (MEFs), in a spontaneous immortalization model, PKD3 has been demonstrated as a critical regulator of cell proliferation after immortalization. However, the mechanisms by which PKD3 regulates proliferation in immortalized MEFs require further elucidation. Using a previously validated -deficient MEF model, we performed a poly-A transcriptomic analysis to identify putative -regulated biological processes and downstream targets in MEFs after spontaneous immortalization. To this end, differentially expressed genes (DEGs) were identified and further analyzed by gene ontology (GO) enrichment and protein-protein interaction (PPI) network analyses to identify potential hub genes. Our results suggest that modulates proliferation through the regulation of gene expression associated with glucose metabolism (, , , ), calcium homeostasis and transport ( and ) and microtubule dynamics ( and ). These candidate processes and associated genes represent potential mechanisms involved in -induced proliferation in spontaneously immortalized cells as well as clinical targets in several cancer types.
细胞永生化对应于一种生物学相关的临床特征,该特征使细胞在癌变过程中获得高增殖潜能。在多种癌症类型中,蛋白激酶D3(PKD3)常被报道为一种失调的致癌激酶,可促进细胞增殖。在自发永生化模型中,利用小鼠胚胎成纤维细胞(MEF)已证明PKD3是永生化后细胞增殖的关键调节因子。然而,PKD3调节永生化MEF细胞增殖的机制仍需进一步阐明。利用先前验证的基因缺陷型MEF模型,我们进行了多聚腺苷酸转录组分析,以确定自发永生化后MEF细胞中假定的基因调控生物过程和下游靶点。为此,我们鉴定了差异表达基因(DEG),并通过基因本体(GO)富集分析和蛋白质-蛋白质相互作用(PPI)网络分析进一步分析,以确定潜在的枢纽基因。我们的结果表明,该基因通过调节与葡萄糖代谢(己糖激酶2、磷酸果糖激酶1、丙酮酸激酶M2和葡萄糖转运蛋白1)、钙稳态和转运(钙调蛋白和肌浆/内质网钙ATP酶2)以及微管动力学(微管蛋白β和驱动蛋白家族成员11)相关的基因表达来调节细胞增殖。这些候选过程和相关基因代表了参与该基因诱导的自发永生化细胞增殖的潜在机制,以及几种癌症类型中的临床靶点。